InvestSMART

ResMed Inc. (ASX: RMD) - Announcements

Current share price for RMD : $32.030 0.23 (0.72%)+

ASX company news and announcements for ResMed Inc. (RMD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ResMed Inc. (RMD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ResMed Inc. (RMD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ResMed Inc. (RMD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$18,941 Resmed Form 10-K Annual Report 14 Aug 2026 8:32AM $31.800 $32.030 risen by 0.72%
$18,941 Statement of changes in beneficial ownership 12 Aug 2026 8:15AM $31.230 $32.030 risen by 2.56%
$18,941 Deferral of Conversions between Australian and US Registers 7 Aug 2026 8:54AM $31.480 $32.030 risen by 1.75%
$18,941 Dividend/Distribution - RMD 7 Aug 2026 8:27AM $31.480 $32.030 risen by 1.75%
$18,941 Resmed Announces Results for the Fourth Quarter of FY2026 7 Aug 2026 8:26AM $31.480 $32.030 risen by 1.75%
$18,941 144 Report of proposed sale of securities 7 Aug 2026 8:25AM $31.480 $32.030 risen by 1.75%
$18,941 Statement of CDIs on issue - RMD 5 Aug 2026 2:37PM $31.525 $32.030 risen by 1.60%
$18,941 Statement of changes in beneficial ownership 10 Jul 2026 8:20AM $30.310 $32.030 risen by 5.67%
$18,941 Resmed Announces Agreement to Sell MatrixCare Business 8 Jul 2026 8:24AM $31.440 $32.030 risen by 1.88%
$18,941 Statement of CDIs on issue - RMD 3 Jul 2026 9:41AM $29.320 $32.030 risen by 9.24%
$18,941 Resmed to Report Fourth Quarter Fiscal 2026 Results 1 Jul 2026 8:18AM $28.880 $32.030 risen by 10.91%
$18,941 Statement of changes in beneficial ownership 10 Jun 2026 8:23AM $28.000 $32.030 risen by 14.39%
$18,941 Statement of changes in beneficial ownership 4 Jun 2026 8:21AM $25.840 $32.030 risen by 23.96%
$18,941 Statement of CDIs on issue - RMD 4 Jun 2026 8:21AM $25.840 $32.030 risen by 23.96%
$18,941 Form SD 27 May 2026 8:25AM $29.250 $32.030 risen by 9.50%
$18,941 Update - Dividend/Distribution - RMD 18 May 2026 8:13AM $28.330 $32.030 risen by 13.06%
$18,941 4 Statement of changes in beneficial ownership 12 May 2026 8:21AM $28.620 $32.030 risen by 11.91%
$18,941 144 Report of proposed sale of securities 11 May 2026 8:17AM $28.560 $32.030 risen by 12.15%
$18,941 Appointment of New Officer 5 May 2026 8:31AM $28.960 $32.030 risen by 10.60%
$18,941 Cessation of Officer Role 5 May 2026 8:22AM $28.960 $32.030 risen by 10.60%
$18,941 Statement of CDIs on issue - RMD 4 May 2026 8:12AM $28.730 $32.030 risen by 11.49%
$18,941 Form 10-Q for the Quarter Ended March 31, 2026 4 May 2026 8:12AM $28.730 $32.030 risen by 11.49%
$18,941 Departure of Directors or Certain Officers 1 May 2026 8:20AM $29.780 $32.030 risen by 7.56%
$18,941 Dividend/Distribution - RMD 1 May 2026 8:19AM $29.780 $32.030 risen by 7.56%
$18,941 Resmed Announces Results for the Third Quarter of FY2026 1 May 2026 8:19AM $29.780 $32.030 risen by 7.56%

1 - 25 of 710 results

Page 1 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.